Profusa (PFSA) Notes Payables (2023 - 2026)
Profusa (PFSA) posted quarterly Notes Payables of $710000.0 for Q1 2026, up 2922.95% year-over-year from $23487.0 in Q1 2025, and down 24.95% quarter-over-quarter from $946000.0 in Q4 2025.
Profusa (PFSA) Notes Payables (2023 - 2026) Analysis & Trends
Profusa's Notes Payables history runs 4 years deep, the most recent figure standing at $710000.0 for Q1 2026.
- In Q1 2026, Notes Payables rose 2922.95% year-over-year to $710000.0; the TTM figure through Mar 2026 stood at $710000.0 (up 2922.95% YoY), while the FY2025 annual figure was $946000.0, up 3.96% from the prior year.
- Notes Payables for Q1 2026 stood at $710000.0, down from $946000.0 in the prior quarter.
- The five-year high for Notes Payables was $10.3 million in Q2 2025, with the low at $23487.0 in Q1 2025.
- The 4-year median for Notes Payables is $945059.0 (2023), against an average of $1.7 million.
- The sharpest annual moves came in 2025 and 2026: Notes Payables sank 98.14% in 2025, then soared 2922.95% in 2026.
- Profusa's Notes Payables stood at $944118.0 in 2023, then decreased by 3.61% to $910000.0 in 2024, then climbed by 3.96% to $946000.0 in 2025, then declined by 24.95% to $710000.0 in 2026.
- Business Quant data shows PFSA's Notes Payables at $710000.0 in Q1 2026, $946000.0 in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.01 Bn | 196.41 Bn | 7.27 Bn |
| 2 | Stryker | 126.44 Bn | 122.97 Bn | 4.50 Bn |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.06 Bn | 73.52 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.70 Bn | 1.35 Bn |
| 6 | Dexcom | 34.80 Bn | 32.86 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.82 Bn | 31.71 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.27 Bn | 22.95 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn |
| 10 | Profusa | 112,089.84 | -262,910.16 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 710,000.00 |
| Dec 31, 2025 | 946,000.00 |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 10.29 Mn |
| Mar 31, 2025 | 23,487.00 |
| Dec 31, 2024 | 910,000.00 |
| Sep 30, 2024 | 1.59 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 944,118.00 |
| Sep 30, 2023 | 601,239.00 |
| Jun 30, 2023 | 310,999.00 |